APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Radiopharmaceuticals

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Therapeutic Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchTherapeutic Radiopharmaceuticals Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Radiopharmaceuticals Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Therapeutic Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Radiopharmaceuticals Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Radiopharmaceuticals Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Therapeutic Radiopharmaceuticals market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Therapeutic Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Therapeutic Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Therapeutic Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Therapeutic Radiopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Therapeutic Radiopharmaceuticals include Aurobindo Pharma, China Isotope & Radiation, Curium Pharmaceuticals, Dongcheng, International Isotopes, Jubilant Radiopharma, Lantheus, Mundipharma and Q BioMed, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Therapeutic Radiopharmaceuticals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Therapeutic Radiopharmaceuticals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Therapeutic Radiopharmaceuticals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Therapeutic Radiopharmaceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

Therapeutic Radiopharmaceuticals Segment by Company

Aurobindo Pharma

China Isotope & Radiation

Curium Pharmaceuticals

Dongcheng

International Isotopes

Jubilant Radiopharma

Lantheus

Mundipharma

Q BioMed

Bayer

Novartis

Therapeutic Radiopharmaceuticals Segment by Type

Lutetium-177

Radium-223

Iodine-131

Other

Therapeutic Radiopharmaceuticals Segment by Application

Bone Metastasis

Thyroid

Lymphoma

Other

Therapeutic Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Therapeutic Radiopharmaceuticals market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Therapeutic Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Therapeutic Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Therapeutic Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Therapeutic Radiopharmaceuticals Industry Trends Table 2. Therapeutic Radiopharmaceuticals Industry Drivers Table 3. Therapeutic Radiopharmaceuticals Industry Opportunities and Challenges Table 4. Therapeutic Radiopharmaceuticals Industry Restraints Table 5. Global Therapeutic Radiopharmaceuticals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Therapeutic Radiopharmaceuticals Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Therapeutic Radiopharmaceuticals Sales Market Share by Manufacturers Table 9. Global Therapeutic Radiopharmaceuticals Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Therapeutic Radiopharmaceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Therapeutic Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Therapeutic Radiopharmaceuticals Manufacturers, Product Type & Application Table 13. Global Therapeutic Radiopharmaceuticals Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Therapeutic Radiopharmaceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Lutetium-177 Table 17. Major Manufacturers of Radium-223 Table 18. Major Manufacturers of Iodine-131 Table 19. Major Manufacturers of Other Table 20. Global Therapeutic Radiopharmaceuticals Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Therapeutic Radiopharmaceuticals Sales by Type (2021-2026) & (k units) Table 22. Global Therapeutic Radiopharmaceuticals Sales by Type (2027-2032) & (k units) Table 23. Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2021-2026) Table 24. Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2027-2032) Table 25. Global Therapeutic Radiopharmaceuticals Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Therapeutic Radiopharmaceuticals Revenue by Type (2021-2026) & (k units) Table 27. Global Therapeutic Radiopharmaceuticals Revenue by Type (2027-2032) & (k units) Table 28. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2021-2026) Table 29. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Bone Metastasis Table 31. Major Manufacturers of Thyroid Table 32. Major Manufacturers of Lymphoma Table 33. Major Manufacturers of Other Table 34. Global Therapeutic Radiopharmaceuticals Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Therapeutic Radiopharmaceuticals Sales by Application (2021-2026) & (k units) Table 36. Global Therapeutic Radiopharmaceuticals Sales by Application (2027-2032) & (k units) Table 37. Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2021-2026) Table 38. Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2027-2032) Table 39. Global Therapeutic Radiopharmaceuticals Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Therapeutic Radiopharmaceuticals Revenue by Application (2021-2026) & (k units) Table 41. Global Therapeutic Radiopharmaceuticals Revenue by Application (2027-2032) & (k units) Table 42. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2021-2026) Table 43. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2027-2032) Table 44. Global Therapeutic Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Therapeutic Radiopharmaceuticals Sales by Region (2021-2026) & (k units) Table 46. Global Therapeutic Radiopharmaceuticals Sales Market Share by Region (2021-2026) Table 47. Global Therapeutic Radiopharmaceuticals Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Therapeutic Radiopharmaceuticals Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Therapeutic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Therapeutic Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 51. North America Therapeutic Radiopharmaceuticals Sales by Country (2027-2032) & (k units) Table 52. Europe Therapeutic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Therapeutic Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 54. Europe Therapeutic Radiopharmaceuticals Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Therapeutic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Therapeutic Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Therapeutic Radiopharmaceuticals Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Therapeutic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Country (2027-2032) & (k units) Table 61. Global Therapeutic Radiopharmaceuticals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Therapeutic Radiopharmaceuticals Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Therapeutic Radiopharmaceuticals Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2021-2026) Table 65. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2027-2032) Table 66. Aurobindo Pharma Company Information Table 67. Aurobindo Pharma Business Overview Table 68. Aurobindo Pharma Therapeutic Radiopharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Aurobindo Pharma Therapeutic Radiopharmaceuticals Product Portfolio Table 70. Aurobindo Pharma Recent Development Table 71. China Isotope & Radiation Company Information Table 72. China Isotope & Radiation Business Overview Table 73. China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. China Isotope & Radiation Therapeutic Radiopharmaceuticals Product Portfolio Table 75. China Isotope & Radiation Recent Development Table 76. Curium Pharmaceuticals Company Information Table 77. Curium Pharmaceuticals Business Overview Table 78. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product Portfolio Table 80. Curium Pharmaceuticals Recent Development Table 81. Dongcheng Company Information Table 82. Dongcheng Business Overview Table 83. Dongcheng Therapeutic Radiopharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Dongcheng Therapeutic Radiopharmaceuticals Product Portfolio Table 85. Dongcheng Recent Development Table 86. International Isotopes Company Information Table 87. International Isotopes Business Overview Table 88. International Isotopes Therapeutic Radiopharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. International Isotopes Therapeutic Radiopharmaceuticals Product Portfolio Table 90. International Isotopes Recent Development Table 91. Jubilant Radiopharma Company Information Table 92. Jubilant Radiopharma Business Overview Table 93. Jubilant Radiopharma Therapeutic Radiopharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Jubilant Radiopharma Therapeutic Radiopharmaceuticals Product Portfolio Table 95. Jubilant Radiopharma Recent Development Table 96. Lantheus Company Information Table 97. Lantheus Business Overview Table 98. Lantheus Therapeutic Radiopharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Lantheus Therapeutic Radiopharmaceuticals Product Portfolio Table 100. Lantheus Recent Development Table 101. Mundipharma Company Information Table 102. Mundipharma Business Overview Table 103. Mundipharma Therapeutic Radiopharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Mundipharma Therapeutic Radiopharmaceuticals Product Portfolio Table 105. Mundipharma Recent Development Table 106. Q BioMed Company Information Table 107. Q BioMed Business Overview Table 108. Q BioMed Therapeutic Radiopharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Q BioMed Therapeutic Radiopharmaceuticals Product Portfolio Table 110. Q BioMed Recent Development Table 111. Bayer Company Information Table 112. Bayer Business Overview Table 113. Bayer Therapeutic Radiopharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Bayer Therapeutic Radiopharmaceuticals Product Portfolio Table 115. Bayer Recent Development Table 116. Novartis Company Information Table 117. Novartis Business Overview Table 118. Novartis Therapeutic Radiopharmaceuticals Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Novartis Therapeutic Radiopharmaceuticals Product Portfolio Table 120. Novartis Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. Therapeutic Radiopharmaceuticals Distributors List Table 124. Therapeutic Radiopharmaceuticals Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Therapeutic Radiopharmaceuticals Product Image Figure 2. Global Therapeutic Radiopharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Therapeutic Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 4. Global Therapeutic Radiopharmaceuticals Sales (2021-2032) & (k units) Figure 5. Global Therapeutic Radiopharmaceuticals Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Therapeutic Radiopharmaceuticals Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Lutetium-177 Image Figure 9. Radium-223 Image Figure 10. Iodine-131 Image Figure 11. Other Image Figure 12. Global Therapeutic Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Therapeutic Radiopharmaceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2021-2032) Figure 15. Global Therapeutic Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Therapeutic Radiopharmaceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2021-2032) Figure 18. Bone Metastasis Image Figure 19. Thyroid Image Figure 20. Lymphoma Image Figure 21. Other Image Figure 22. Global Therapeutic Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Therapeutic Radiopharmaceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2021-2032) Figure 25. Global Therapeutic Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Therapeutic Radiopharmaceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2021-2032) Figure 28. North America Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Therapeutic Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 30. U.S. Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Therapeutic Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 35. Germany Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Therapeutic Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 42. China Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Therapeutic Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 50. Brazil Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Therapeutic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Therapeutic Radiopharmaceuticals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Therapeutic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 61. North America Therapeutic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Therapeutic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 63. Europe Therapeutic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Therapeutic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Therapeutic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Therapeutic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Therapeutic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Therapeutic Radiopharmaceuticals Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Therapeutic Radiopharmaceuticals Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Lutetium-177
  • Radium-223
  • Iodine-131
  • Other
Applications
  • Bone Metastasis
  • Thyroid
  • Lymphoma
  • Other
Companies covered
  • Aurobindo Pharma
  • China Isotope & Radiation
  • Curium Pharmaceuticals
  • Dongcheng
  • International Isotopes
  • Jubilant Radiopharma
  • Lantheus
  • Mundipharma
  • Q BioMed
  • Bayer
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Therapeutic Radiopharmaceuticals Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Therapeutic Radiopharmaceuticals Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Therapeutic Radiopharmaceuticals Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Therapeutic Radiopharmaceuticals Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Therapeutic Radiopharmaceuticals Market Dynamics
  1. 2.1 Therapeutic Radiopharmaceuticals Industry Trends
  2. 2.2 Therapeutic Radiopharmaceuticals Industry Drivers
  3. 2.3 Therapeutic Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Therapeutic Radiopharmaceuticals Industry Restraints
3 Therapeutic Radiopharmaceuticals Market by Manufacturers
  1. 3.1 Global Therapeutic Radiopharmaceuticals Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Therapeutic Radiopharmaceuticals Sales by Manufacturers (2021-2026)
  3. 3.3 Global Therapeutic Radiopharmaceuticals Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Therapeutic Radiopharmaceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Therapeutic Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Therapeutic Radiopharmaceuticals Manufacturers, Product Type & Application
  7. 3.7 Global Therapeutic Radiopharmaceuticals Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Therapeutic Radiopharmaceuticals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Therapeutic Radiopharmaceuticals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Therapeutic Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 Therapeutic Radiopharmaceuticals Market by Type
  1. 4.1 Therapeutic Radiopharmaceuticals Type Introduction
  2. 4.1.1 Lutetium-177
  3. 4.1.2 Radium-223
  4. 4.1.3 Iodine-131
  5. 4.1.4 Other
  6. 4.2 Global Therapeutic Radiopharmaceuticals Sales by Type
  7. 4.2.1 Global Therapeutic Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Therapeutic Radiopharmaceuticals Sales by Type (2021-2032)
  9. 4.2.3 Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2021-2032)
  10. 4.3 Global Therapeutic Radiopharmaceuticals Revenue by Type
  11. 4.3.1 Global Therapeutic Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Therapeutic Radiopharmaceuticals Revenue by Type (2021-2032)
  13. 4.3.3 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2021-2032)
5 Therapeutic Radiopharmaceuticals Market by Application
  1. 5.1 Therapeutic Radiopharmaceuticals Application Introduction
  2. 5.1.1 Bone Metastasis
  3. 5.1.2 Thyroid
  4. 5.1.3 Lymphoma
  5. 5.1.4 Other
  6. 5.2 Global Therapeutic Radiopharmaceuticals Sales by Application
  7. 5.2.1 Global Therapeutic Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Therapeutic Radiopharmaceuticals Sales by Application (2021-2032)
  9. 5.2.3 Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2021-2032)
  10. 5.3 Global Therapeutic Radiopharmaceuticals Revenue by Application
  11. 5.3.1 Global Therapeutic Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Therapeutic Radiopharmaceuticals Revenue by Application (2021-2032)
  13. 5.3.3 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2021-2032)
6 Global Therapeutic Radiopharmaceuticals Sales by Region
  1. 6.1 Global Therapeutic Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Therapeutic Radiopharmaceuticals Sales by Region (2021-2032)
  3. 6.2.1 Global Therapeutic Radiopharmaceuticals Sales by Region (2021-2026)
  4. 6.2.2 Global Therapeutic Radiopharmaceuticals Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Therapeutic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Therapeutic Radiopharmaceuticals Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Therapeutic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Therapeutic Radiopharmaceuticals Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Therapeutic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Therapeutic Radiopharmaceuticals Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Therapeutic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Therapeutic Radiopharmaceuticals Revenue by Region
  1. 7.1 Global Therapeutic Radiopharmaceuticals Revenue by Region
  2. 7.1.1 Global Therapeutic Radiopharmaceuticals Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Therapeutic Radiopharmaceuticals Revenue by Region (2021-2026)
  4. 7.1.3 Global Therapeutic Radiopharmaceuticals Revenue by Region (2027-2032)
  5. 7.1.4 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Therapeutic Radiopharmaceuticals Revenue (2021-2032)
  8. 7.2.2 North America Therapeutic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Therapeutic Radiopharmaceuticals Revenue (2021-2032)
  11. 7.3.2 Europe Therapeutic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Therapeutic Radiopharmaceuticals Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Therapeutic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Therapeutic Radiopharmaceuticals Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Therapeutic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aurobindo Pharma
  2. 8.1.1 Aurobindo Pharma Company Information
  3. 8.1.2 Aurobindo Pharma Business Overview
  4. 8.1.3 Aurobindo Pharma Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aurobindo Pharma Therapeutic Radiopharmaceuticals Product Portfolio
  6. 8.1.5 Aurobindo Pharma Recent Developments
  7. 8.2 China Isotope & Radiation
  8. 8.2.1 China Isotope & Radiation Company Information
  9. 8.2.2 China Isotope & Radiation Business Overview
  10. 8.2.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 China Isotope & Radiation Therapeutic Radiopharmaceuticals Product Portfolio
  12. 8.2.5 China Isotope & Radiation Recent Developments
  13. 8.3 Curium Pharmaceuticals
  14. 8.3.1 Curium Pharmaceuticals Company Information
  15. 8.3.2 Curium Pharmaceuticals Business Overview
  16. 8.3.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product Portfolio
  18. 8.3.5 Curium Pharmaceuticals Recent Developments
  19. 8.4 Dongcheng
  20. 8.4.1 Dongcheng Company Information
  21. 8.4.2 Dongcheng Business Overview
  22. 8.4.3 Dongcheng Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dongcheng Therapeutic Radiopharmaceuticals Product Portfolio
  24. 8.4.5 Dongcheng Recent Developments
  25. 8.5 International Isotopes
  26. 8.5.1 International Isotopes Company Information
  27. 8.5.2 International Isotopes Business Overview
  28. 8.5.3 International Isotopes Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 International Isotopes Therapeutic Radiopharmaceuticals Product Portfolio
  30. 8.5.5 International Isotopes Recent Developments
  31. 8.6 Jubilant Radiopharma
  32. 8.6.1 Jubilant Radiopharma Company Information
  33. 8.6.2 Jubilant Radiopharma Business Overview
  34. 8.6.3 Jubilant Radiopharma Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jubilant Radiopharma Therapeutic Radiopharmaceuticals Product Portfolio
  36. 8.6.5 Jubilant Radiopharma Recent Developments
  37. 8.7 Lantheus
  38. 8.7.1 Lantheus Company Information
  39. 8.7.2 Lantheus Business Overview
  40. 8.7.3 Lantheus Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lantheus Therapeutic Radiopharmaceuticals Product Portfolio
  42. 8.7.5 Lantheus Recent Developments
  43. 8.8 Mundipharma
  44. 8.8.1 Mundipharma Company Information
  45. 8.8.2 Mundipharma Business Overview
  46. 8.8.3 Mundipharma Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mundipharma Therapeutic Radiopharmaceuticals Product Portfolio
  48. 8.8.5 Mundipharma Recent Developments
  49. 8.9 Q BioMed
  50. 8.9.1 Q BioMed Company Information
  51. 8.9.2 Q BioMed Business Overview
  52. 8.9.3 Q BioMed Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Q BioMed Therapeutic Radiopharmaceuticals Product Portfolio
  54. 8.9.5 Q BioMed Recent Developments
  55. 8.10 Bayer
  56. 8.10.1 Bayer Company Information
  57. 8.10.2 Bayer Business Overview
  58. 8.10.3 Bayer Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bayer Therapeutic Radiopharmaceuticals Product Portfolio
  60. 8.10.5 Bayer Recent Developments
  61. 8.11 Novartis
  62. 8.11.1 Novartis Company Information
  63. 8.11.2 Novartis Business Overview
  64. 8.11.3 Novartis Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novartis Therapeutic Radiopharmaceuticals Product Portfolio
  66. 8.11.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Therapeutic Radiopharmaceuticals Value Chain Analysis
  2. 9.1.1 Therapeutic Radiopharmaceuticals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Therapeutic Radiopharmaceuticals Production Mode & Process
  6. 9.2 Therapeutic Radiopharmaceuticals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Therapeutic Radiopharmaceuticals Distributors
  9. 9.2.3 Therapeutic Radiopharmaceuticals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst